National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$49.95
add to cart

Rights & Permissions

topleft topright

Risk Assessment of Radon in Drinking Water (1999)
Commission on Life Sciences (CLS)

Citation Manager

. "4 Dosimetry of Ingested Radon and its Associated Risk." Risk Assessment of Radon in Drinking Water. Washington, DC: The National Academies Press, 1999.

Please select a format:

BibTeX EndNote RefMan


Page
80
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


4. Lifetime cancer risk for chronic intakes

For purposes of computing a risk coefficient, it is assumed that the radon concentration in the drinking water remains constant and that all persons in the population are exposed to that concentration throughout their lifetimes. It is assumed that the lifetime average drinking water consumption rate is 0.6 L d-1.

For each cancer site and each sex, the lifetime cancer risk for chronic intakes is obtained by integration over age x of the product of the lifetime cancer risk per unit intake at age x and the expected drinking water consumption at age x.

Except for the calculations of the time-dependent organ activities and absorbed-dose rates, each of the steps described above is performed separately for each sex and each cancer site. A total-risk coefficient is derived by first adding the risk estimates for the different cancer sites in each sex and then calculating a weighted mean of the coefficients for males and females. The weighted mean of coefficients for males and females involves the presumed sex ratio at birth, the sex-specific risk per unit intake at each age, and the sex-specific survival function at each age.

The cancer mortality risks associated with lifetime ingestion of 222Rn dissolved in drinking water at a concentration of 1 Bq m-3 are given in table 4.7; the total average over both sexes is 1.9 × 10-9. The uncertainty in this estimate is associated largely with the estimated dose to the stomach and with the epidemiologic data used to estimate the risk. Cancer of the stomach is a major late effect in

Table 4.7

Cancer Mortality Risk Associated with Lifetime Ingestion of 222Rn at a Concentration of 1 Bq m-3 in Drinking Watera

 

Cancer Mortality Risk (m3 Bq-1)

Cancer Site

Males

Females

Both Sexes

Esophagus

1.5E-12

3.3E-12

2.2E-12

Stomach

1.3E-09

2.0E-09

1.6E-09

Colon

4.6E-11

7.7E-11

5.9E-11

Liver

6.8E-11

4.4E-11

5.8E-11

Lung

2.6E-11

4.5E-11

3.4E-11

Bone

5.4E-12

5.7E-12

5.5E-12

Breast

1.0E-11

4.5E-12

Ovary

6.1E-12

2.6E-12

Bladder

7.8E-12

3.7E-12

6.0E-12

Kidney

1.8E-11

1.1E-11

1.5E-11

Thyroid

1.3E-12

3.1E-12

2.1E-12

Leukemia

1.9E-11

1.5E-11

1.7E-11

Residualb

6.9E-11

9.2E-11

7.9E-11

Total

1.5E-09

2.3E-09

1.9E-09

a To express risk in the conventional units (L pCi-1), multiply the values by 37.

b The average of the absorbed dose rates to muscle, pancreas, and adrenals is applied to this group of Cancers.

Page
80